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Autism is one of a group of developmental disorders that have devastating lifelong effects on its
victims. Despite the severity of the disease and the fact that it is relatively common (15 in 10,000),
there is still little understanding of its etiology. Although believed to be highly genetic, no abnormal
genes have been found. Recent findings in autism and in related disorders point to the possibility
that the disease is caused by a gene-environment interaction. Epidemiologic studies indicate that
the number of cases of autism is increasing dramatically each year. It is not clear whether this is
due to a real increase in the disease or whether this is an artifact of ascertainment. A new theory
regarding the etiology of autism suggests that it may be a disease of very early fetal development
(approximately day 20-24 of gestation). This theory has initiated new lines of investigation into
developmental genes. Environmental exposures during pregnancy could cause or contribute to
autism based on the neurobiology of these genes. Key words: autism, autism epidemiology, autism
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The autism spectrum disorders (otherwise
known as the pervasive developmental disor-
ders) include autistic disorder as well as perva-
sive developmental disorder not otherwise
specified and Asperger's syndrome. These
three are all widely believed to be develop-
mental brain disorders. It is quite likely that
there are environmental factors that con-
tribute to the brain pathology which yields
the symptoms found in autism.
Diagnostically, the autism spectrum
disorders are highlighted by a triad ofsymp-
toms. These include language disturbance,
social impairment, and a rigid adherence to
sameness (1,2). There is a spectrum ofsever-
ity of these symptoms ranging from being
"almost normal" to completely nonfunction-
ing. The language disturbance ranges from
"odd" to totally nonverbal. At the severe end
of the spectrum, the disease takes an enor-
mous toll on both the affected individual and
the family. Often the family is drawn into a
lifelong care-taking role and family members
may abandon much ofwhat may be consid-
ered a normal healthy life. One study (3) con-
cluded that the amount offamily stress was
significantly higher in families with an autis-
tic family member than in families affected by
a fatal disease like cystic fibrosis.
Conservatively, autism spectrum disorders
affect over 400,000 people in the United States
(4,5). Although autism is one of the most
severe in terms ofmorbidity, other develop-
mental brain disorders are far more prevalent.
There are an estimated 7 million individuals
with mental retardation in America (6). At the
other end ofthe spectrum ofdevelopmental
brain disorders, Attention Deficit Disorder and
learning disabilities are each estimated to occur
in up to 10% of the population (7). This
would bring the total population ofpeople
with developmental brain disorders in the
United States to over 20 million individuals.
Except for a few types ofmental retardation
such as Down's syndrome and Fragile X syn-
drome, the etiology ofthe developmental brain
disorders is unknown. The most common eti-
ology ofmental retardation is "mental retarda-
tion ofunknownorigin."
Environmental factors can cause develop-
mental disabilities. Obvious examples are
fetal alcohol syndrome and phenylketonuria
(considering phenylalanine as the environ-
mental agent). Despite the severity and
prevalence ofthis group ofdiseases, and with
the likelihood that environmental influences
are at least partially responsible, there has
been little research in this field. Weiss (8), in
a review ofpesticides as causes ofdevelop-
mental disorders, pointed out that our
knowledge ofhow those agents modify the
course ofbrain development is "disturbingly
sparse," and offers four areas ofdeficiency in
our knowledge. These areas are a) a lack of
epidemiologic studies based on developmen-
tal exposure; b) a lack of animal models
addressing development, including wide dos-
ing ranges to simulate environmental reali-
ties; c) the fact that animal studies use crude
behavioral end points rather than more
sophisticated ones such as intellectual devel-
opment; and d) the fact that longitudinal
lifetime experiments are rarely aimed at neu-
robehavioral end points (therefore preempt-
ing the study ofsymptoms emerging later in
life). For example, autism is not usually diag-
nosed until approximately 18 months ofage
despite evidence ofprenatal changes in the
brain. Weiss' observations could be general-
ized to include all environmental research on
the developmental disorders rather than just
research on pesticides.
We describe the current state ofenviron-
mental research in autism to illustrate the
issues faced by those interested in pursuing the
etiology of developmental brain disorders.
Because this work is in its infancy, we include
not only the existing research but also some of
the newer hypotheses. We believe that investi-
gating environmental factors in the etiology of
autismwill be a fruitful avenue to pursue.
Autism and the Interaction
of Genes and Environment
Although the etiology ofautism is not under-
stood, there is clearly a genetic component to
autism spectrum disorders (9,10). This has
been established through twin and family
studies. There is a concordance rate ofapprox-
imately 2-6% in dizygotic twins as opposed
to the 66% concordance rate in monozygotic
twins. This 2-6% rate is also the rate esti-
mated for family recurrence, which should be
compared to the approximate rate of
0.1-0.15% in the general population. Despite
the evidence ofa genetic component, how-
ever, genetics does not explain the whole pic-
ture (1,9). Autism is most likely a
"multifactorial" disorder. Wide-ranging phe-
notypes, both within families as well as within
the monozygotic twins studied, suggest that
simple modes ofinheritance are not operative.
Furthermore, case reports ofautism associated
with environmental factors, such as rubella
virus, valproic acid, and thalidomide exposure
during pregnancy, lead many researchers to
postulate that nongenetic mechanisms may
also produce an autistic syndrome.
Virtually all of the psychiatric disorders
appear to be syndromes genetically comprised
ofcomplex traits. Psychiatric diagnoses based
on the Diagnostic and StatisticalManual of
Mental Disorders, 4th edition (American
PsychiatricAssociation, Washington, DC) are
phenomenologic and not etiologically based.
This simple but often overlooked fact has a
profound effect on the search for etiologies.
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Another way of stating the above is that
psychiatric diagnoses are merely statistically
based groupings ofsymptoms. Alongwith the
formal diagnosis ofautistic disorder, there is
wide acceptance ofan entity known as the
broader autistic phenotype. The meaning of
the broader phenotype is that autistic traits
such as language disturbance, social distur-
bance, and learning disorders are significantly
more common in the families of autistic
probands (11-13). For example, although the
concordance for autism in identical twins is
approximately 66%, it is about 93% for the
broader phenotype (14). Similarly, the rate in
dizygotic twins for concordance for the
broader phenotype is approximately 15%
rather than 2-6%. The understanding that
affected family members may have some of
the genetic makeup ofautism without having
the disease has led many investigators to pos-
tulate the concept ofsusceptibility genes for
autism. Ifthis is the case, perhaps itwould be
necessary to have both these susceptibility
genes as well as some environmental regula-
tion ofthese genes to produce autism.
Like most of the psychiatric illnesses,
autism appears to be a syndrome ofcomplex
genetic traits (15). These traits are pheno-
types that do not exhibit classic Mendelian
recessive or dominant inheritance attributable
to a single gene locus. This can happen either
because different genotypes can result in the
same phenotype or because the same geno-
type can result in multiple phenotypes. The
latter can be the result ofgenetic interactions
with the environment orwith othergenes.
A gene associated with Rett's syndrome
was recently identified (16). This is believed
to be the first gene associated with a specific
disease that has a role in the epigenetic regu-
lation ofgene expression and is therefore a
gene which could explain the clinical appear-
ance of these complex traits. It should be
noted that this mutation was found in
approximately 30% of those studied.
Although regulatory genes are an exciting
prospect for the explanation of complex
genetic illnesses, the environmental regulatory
role should not be considered less significant.
The research on psychiatric illnesses has not
identified abnormal genes. This led Kandel
(17) to muse that "certain combinations of
normal genes against a certain genetic back-
ground ... may predispose people to getting
schizophrenia. And if the latter is the case,
then finding any gene by itself may not be
helpful because it may be a normal gene." If
this turns out to be the situation in autism,
then studying the expression of the genes
(and their regulators) may give us more clues
to understanding its etiology.
Genes have two roles: the template
function (replication) and the transcriptional
function (which is responsible for the
structure, function, and other biological
characteristics ofthe cell). In this process, the
DNA codes for and creates the RNA, which
then goes on to code for and create the pro-
teins. Although the template function is
largely independent ofoutside forces, the tran-
scriptional function is highly regulated and
responsive to environmental factors (18).
These environmental factors could be toxi-
cants, viruses, or hormones. As an everyday
example, the process oflearning has a direct
effect on an organism's genes and their func-
tioning. Environmental stimuli guide the neu-
rons to grow, synapse, or perhaps die
according to what is needed. If even the
physiologic interaction with the environment
alters genetic functioning, the role ofoutside
toxicants or ofdisturbed metabolism due to
toxicants can also have the same result.
Although there is evidence that exposure to a
distinct environmental factor during pregnancy
(i.e., infection with Rubella virus) can cause an
autistic syndrome, the most likely avenue for
fertile researchwill be in thegene-environment
interaction.
Epidemiology ofAutism
Is the prevalence of autism increasing?
Throughout the 1960s and 1970s the preva-
lence ofautism was believed to be 2-5 in
10,000. Nearly all of the epidemiologic
studies done before 1985 reflected findings in
that range (5). Since 1985, however, 10 of 11
studies done outside of the United States
showed rates of9 per 10,000 or more. There
have also been some studies, the most detailed
with respect to case-finding, that showed rates
of > 20 per 10,000. However, these studies
were performed on small populations. One
group performed repeated studies in the same
geographic area in Goteborg, Sweden (5). In
1980 they reported a prevalence of 4 per
10,000; in 1984 prevalence was 7.6 per
10,000, and in 1988 prevalence was 11.5 per
10,000. Gillberg and Wing (5) estimated that
based on worldwide epidemiologic studies
autism appears to be increasing at a rate of
3.8% per year. It is not clear whether the
apparent rise in prevalence is a real increase or
afunction ofbetterascertainment.
In April 1999, the state of California
reported an increase of210% in the autism
population receiving services through its
regional centers (19). Regional centers are
those state-supported institutions with
responsibility for providing services to the
developmentally disabled population. It is
likely that most families with developmental
disabilities would utilize these resources, so it
is probably a good representation ofthe rela-
tive prevalence ofautism. The 210% rise in
autism is compared to an approximately 60%
increase in total population that the regional
centers served between 1987 and 1998.
Although the report emphasized that this is
not an epidemiologic study, the extreme
increase in numbers is striking and has led the
state ofCalifornia tostudy autism further.
The Brick Township Cluster
Brick Township, NewJersey, is a rural town-
ship close to several Superfund sites. The num-
ber of autistic children in the township,
combinedwith existing concerns overenviron-
mental issues, led a group ofparents in the
township to begin informal surveillance for
autism. They placed ads in local newspapers
asking for parents ofautistic children to iden-
tify themselves. Many individuals responded,
which, ifconfirmed, would indicate that the
prevalence ofautism in Brick Township was
much higher than the usually cited prevalence.
These observations led the Centers for Disease
Control and Prevention (CDC) (Atlanta, GA)
and the Agency for Toxic Substances and
Disease Registry (ATSDR) (Atlanta, GA) to
conduct an investigation. On 22 May 2000,
the reports ofboth agencies were made public.
The CDC, using the Autism Diagnostic
Observation Schedule-Generic to confirm
diagnoses, found that the prevalenceforstrictly
defined autism was 4 per 1,000 and that the
prevalence for strictly defined autism was 6.7
per 1,000 (20). These prevalence figures are
approximately 4 times higher than the 1 per
1,000 most frequently cited in the literature.
The ATSDR studied the township environ-
mentally and found three contaminants in the
drinking water at various times (21). These
substances were tetrachloroethylene,
trichloroethylene, and trihalomethanes
(THMs). In all three cases there was no evi-
dence ofa link between the location and/or
timing ofthe abnormal values and the indexed
cases ofautism. The most interesting finding,
however, is that THMs within the same range
as found in Brick Township have been associ-
ated with a 2-fold increase in neural tube
defects (22,23). This findingshould be consid-
ered in the context ofRodier's research (24),
which hypothesizes that autism may be caused
byaneural tubedefect.
Because ofthe lack ofsurveillance, we do
not know the prevalence ofautism worldwide
or in the United States. Nor do we know ifthe
prevalence is uniform in its distribution or
higher in some geographic areas than others. It
is not clear whether the disease is rising in
prevalence. In 1995, theworkinggroupon epi-
demiology ofthe National Institutes ofHealth
(NIH) autism committee conduded that there
was no needforundertaking furtherepidemiol-
ogy study in the United States (25). In the last
year, however, the NIH indicated a renewed
interest in autism epidemiology in its call for
proposals. To study environmental causes of
autism and to understand its prevalence, rate of
increase, andgeographic dusteringarecrucial.
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The Neurobiology ofAutism
Much ofwhat we can deduce about the etiol-
ogy ofautism comes from two neuropatho-
logic studies ofpostmortem samples (26,27).
Evidence that there are limbic system abnor-
malities is based both on neuropathological
findings as well as neuropsychological theory
(28). New research on cognitive brain mecha-
nisms point to cerebellar malfunctioning as a
central explanation for many ofthe signs and
symptoms ofautism, including the cognitive
deficits (29). This is underscored by neuro-
pathological and neuroimaging findings that
point to the cerebellum as being abnormal.
Although there are some inconsistent find-
ings, there also have been some findings
found uniformly in all postmortem tissue
examined. In all of the brains studied,
Purkinje cell numbers were diminished with-
out the presence ofempty baskets. This sug-
gests that it is unlikely that these cells were
lost but rather that there was a very early
developmental abnormality. Evidence of
abnormal neuronal migration appears to be
present in the brain stem, cerebellum, and the
cortex. These abnormalities indicate that the
brain lesions in autism occurred very early in
fetal development. Although we cannot rule
out the possibility that there are insults to the
brain postnatally, any explanation ofthe eti-
ology will have to explain these early develop-
mental brain changes. Therefore, for those
who are interested in investigating possible
environmental causes ofautism, the in utero
period is acrucial time to study (26,27,30).
There is not a good animal model for
autism. A disease that is characterized by lan-
guage and social impairment is hard to
demonstrate or test in animals. Nevertheless,
this is an area ofhigh priority and recently
led the NIH to sponsor a conference on ani-
mal models in autism. The conference,
Building Animal Models for Autism
Through Translational Neuroscience
Research, held 5-6 October 1998 in Santa
Monica, California, generated several new
strategies for the development of an animal
model. Even with an animal model, assessing
the effects of various toxicants is difficult.
Wide ranges ofdoses and varied exposure
times must be studied. The developmental
aspect ofthe brain in terms ofthe effect ofa
toxicant is especially important. Better
behavioral measures will also be needed to
determine the effects that these substances
have on thedeveloping brain.
Autism as a Birth Defect
On 10-11 April 1995 the NIH held the
Autism State-of-the-Science Conference in
Bethesda, Maryland. Genetics research was
reviewed, but scant attention was given to
any other etiologic hypotheses. At that time,
there was no literature to support any
environmental factor or even an environmen-
tal hypothesis. However, at approximately the
same time, a group ofophthalmologists was
studying the Swedish thalidomide survivor
population (31). Eighty-six people who had
been exposed to thalidomide in utero were
examined for ocular motor defects. In this
group, 15 patients with early exposure to the
drug had external ear malformations but no
limb abnormalities. This would suggest that
they were exposed to the thalidomide
between days 20 and 24 ofgestation. Ofthe
86 there were 4 who were autistic. All 4
patients were among the 15 who had the
early exposure to thalidomide; no cases of
autism were found outside ofthat window of
exposure.
The hypothesis that autism could be
caused by a disturbance ofneural tube closure
was formulated by Rodier (24) based on this
research. The neural tube closure process
occurs during the gestation day 20-24 time-
frame. This was a breakthrough in thinking
about the etiology of autism and could be
described as the first evidence-based etiologic
hypothesis ofautism. To further explore this
theory, Rodier et al. (32) have pursued several
lines of investigation. Examination ofsome
postmortem tissue has shown abnormalities
in the brainstem structures also formed dur-
ing that same time period. Elevated levels of
cranial nerve abnormalities have been
reported; however, because oftheir relatively
minor clinical importance, they have been
somewhat overlooked. A rat model has been
produced by using valproic acid (another
interrupter ofneural tube closure), which
yielded reductions in the numbers ofneurons
in cranial nerve nuclei as well as malformed
ears. Rodier et al. (32) also noted a decrease
in the number ofPurkinje cells in the cerebel-
lum. These findings are similar to those
reported in the postmortem studies of indi-
viduals with autism (26,27).
These findings led researchers to explore
the possibility ofa candidate gene being etio-
logically involved in autism. The genes come
from the family known as the Hoxgenes. This
family comprises 38 different genes and is
expressed during embryonic development.
They pattern for many body structures,
induding the limbs, skeleton, and the nervous
system. There is literature to support the fact
that knockout mice lacking Hoxal and Hoxbl
have some ofthe same abnormalities as theval-
proate rat aswell as the dinical cases ofautism.
This suggests that the abnormality in develop-
ment in autism might be mediated through
these genes. Preliminary work from this group
suggests that allelic variants of HOXAI occur
at a higher rate among autistic probands than
in several control groups. Another interesting
finding is that these variant alleles were not rare
in the control populations (33).
Ifthese findings are correct, this would
have a major impact on the relevance ofenvi-
ronmental exposures to the etiology of
autism. It suggests that the genes responsible
for autism might be thought ofas susceptibil-
ity genes. Perhaps the genes mediate only the
broader phenotype (which appears to be even
more heredible). To have the full autistic syn-
drome we might need the genetic predisposi-
tion as well as some other event or exposure,
most likely in utero. The HOXAI findings
raise the possibility that, with a candidate
gene identified, the task offinding environ-
mental exposures that contribute to autism is
at hand.
Retinoid Research
The theory that autism is caused by an abnor-
mality in development at the time of neural
tube closure has opened the door to looking
at retinoic acid as a possible environmental
factor. Converging lines ofevidence make
looking at this compound compelling.
The retinoids can be powerful teratogens.
The study of this topic is, however, quite
complicated. One major finding that compli-
cates the picture is that the effects of the
retinoids (as well as other toxicants that inter-
rupt neural tube closure) are species depen-
dent. Thalidomide, for example, can produce
limb malformations in humans and most sub-
human primates. The defects can be produced
in rabbits at high doses, but rats and mice are
not susceptible. Three albino rat strains differ
in their responses to excess vitamin A. Dosing
and timing ofthe retinoid exposure also yield
verydifferent results (34).
Both an excess and a deficiency ofvita-
min A during pregnancy are associated with
birth defects, specifically neural tube defects
[the same type of damage postulated by
Rodier to occur in autism (24)] (35). In
1995, the Food and Drug Administration
issued new recommendations warning
women in their childbearing years to limit
their Vitamin A intake to 5,000 IU (36).
In a survey of22,000 women, Rothman
et al. (37) reported much higher rates of
birth defects in those women who took
excessive doses of vitamin A during preg-
nancy. This study has been criticized by sev-
eral authors (38). Mastroiacovo et al. (39)
did not find the same correlation between
high levels of vitamin A and birth defects.
From the point ofview of autism research,
however, the fact is that in both studies the
data were collected shortly after the delivery
of the baby. Because of this, neither study
would have been able to identify any cases of
autism, as autism usually presents around
the second year of life. In addition, the
studies would not have been able to identify
more subtle abnormalities of cognition that
may need to be measured in early childhood.
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Besides Vitamin A, there are other forms
ofretinoids to which women may be exposed
during pregnancy. There are several retinoid-
based medications, including isotretinoin, an
acne medication. Isotretinoin causes birth
defects including hindbrain abnormalities that
resemble the brain abnormalities in autism
(40). The evidence that retinoids are capable
ofbeing teratogens is ofimportance because
these compounds are used in treatment of
skin diseases as well as in cancer treatments.
To date, there have been more than 10,000
retinoids isolated or synthesized for potential
pharmacological application (34).
Animal models using retinoic acid have
been developed and share many of the spe-
cific brain lesions associated with autism
including cerebellar malformations, cranial
nerve abnormalities, and abnormalities ofthe
dopaminergic system.
Retinoids mayalso bedirect environmental
pollutants, although this may not be the mech-
anism by which this group ofcompounds
influences brain development in autism. It is
likely that other forms oftoxicants may inter-
fere with retinoid metabolism. Various chemi-
cals (such as polychlorinated biphenyls) and
hormones (such as thyroid hormones) can alter
retinoid metabolism (41). Valproic acid, which
is believed to be a possible etiologic agent for
autism, also alters retinoid metabolism (42).
Perhaps the most interesting nexus
between the retinoids and autism is the fact
that they are known modifiers of Hox genes
(35). It is quite possible that the findings of
birth defects caused by retinoids are mediated
through their properties as genetic modifiers.
The Casefor Environmental
Research in Autism
At this point the evidence for an environmen-
tal origin for autism is circumstantial. Direct
evidence for any etiology in autism is thus far
lacking. Nevertheless, we contend that there
are ample reasons for environmental research
to be undertaken.
Although autism is a highly heritable dis-
ease, no genes or even areas ofinterest have
emerged as highlysignificant. Rather than con-
tinuing to search for abnormal genes, a more
productive strategy maybe to studythe expres-
sion ofthe genes. New techniques such as the
use ofmicroarrays enable the direct examina-
tion ofgene expression in brain tissue. The
widephenotypic variation even in some identi-
cal twins further points to gene expression
rather than justgenotypic abnormalities as part
ofthe etiologic mechanism. Studies ofthe reg-
ulator genes as well as environmental regula-
tors can be looked at as a fruitful strategy.
Environmentally induced animal or even tissue
models mayhelp to identifycandidate genes.
The embryologic origins ofautism further
give a direction for investigators. The neuro-
biology of the prenatal developmental
processes, and the environmental exposures
that can effectuate those changes, may be a
clue leading to an understanding of the ori-
gins ofautism. An example might be dysmor-
phic facial and body features. The fact that
environmental factors (such as retinoids) can
produce these changes in the same children
who have diseases such as autism might lead
us toward the mechanisms ofabnormal brain
formation.
Studies such as the Brick Township
surveillance, yielding either an increased
prevalence or geographic clustering, would
further open the possibilities that an environ-
mental factor could be found. This study has
a component to look for environmental fac-
tors that may be linked to autism.
We have attempted to outline some of
the emerging concepts in understanding the
etiology ofautism. To advance the research,
various lines of investigation must be pur-
sued, including identifying genetic abnor-
malities and studying the basic neurobiology
of the disease. Epidemiologic studies of
autism should be undertaken. The environ-
mental scientist has a great deal to contribute
to the understanding of autism and other
developmental brain diseases.
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